3/ Even though female executives are sparse among healthcare ranks, 26 percent of its executives are women. It's among the highest of any industry, alongside finance and retail….
4/ But-Female executives are concentrated in C-suite roles like chief human resource officer positions (where 55% are women) and chief marketing officers (36%), Investopedia reported.
5/ At Fortune 500 companies, just 1 in 13 companies is led by a woman. In total, 37 companies have a woman as CEO, which is the highest number of women leading a top company in American history.
7/ One reason there are so few female CEOs is that the pipeline is shrinking, IBM found. The number of women in roles that lead to executive positions has been declining since 2019. Stanford researchers found women make up just 13% of the leadership pipeline @aayshacader
8/ Another factor is that women are holding fewer seats at the top MBA programs vs male counterparts. It took the Wharton School of the University of Pennsylvania in Philadelphia 140 years to welcome a class with more women than men, the first of any elite program @ShrillaB
9/ Even women who make it to the top encounter challenges that may weigh on their tenure. 3 out of 4 female executives reported feeling imposter syndrome at some point in their career, a study by consultant firm KPMG found @NadeenFaza@drmalissawood@AnnMarieNavar@noshreza
10/ Women also receive less leadership transition support than men. Men are 13 percent more likely to receive leadership skills training than women and are 22 percent more likely to be assigned a formal mentor @MeeraDas@purviparwani@SamRRazaMD
11/ Perceptions on what makes a good leader are skewed by gender role assumptions. 💃🏻leaders are often plagued by sexist stereotypes that label them "too emotional" for leadership. To be deemed an effective leader they have to limit themselves to 3 emotions: cheer, calm and pride
• • •
Missing some Tweet in this thread? You can try to
force a refresh
@ASPCardio Statement: Defining Preventive Cardiology
🫀Noted ⤵️ in mortality from CVD over the past several decades driven by progress in prevention
🫀More recently CVD mortality ⬆️ w/ ⬆️ risk factors at younger ages
🫀Our goal was to define the field of preventive cardiology
@ASPCardio proposed a unifying definition of preventive cardiology: proactive, patient-centered approach in which clinician, or team of clinicians and non-clinicians, assesses CV risk & implements a comprehensive strategy of risk mitigation to prevent CVD & its clinical sequelae.
CVD Prevention goes far beyond LDL.
Lifestyle Approaches are key and we have had @ASPCardio statements on this, including the role of nutrition on heart health led by @DBelardoMD and myself, with the collaboration of many others
👉Rate of ⬆️ of #WIC is just 0.3%/year
👉No Federal Mandate for Maternity Leave in🇺🇸
👉Issues related to childbearing affect practicing cardiologists
💃purpose of this study was to examine
the impact of pregnancy & maternity leave &
associated institutional policies/practices WIC
📌323 Respondents: ~35% of #WIC so quite good for a survey
📌Practices: Academic🎓/Hospital🏥/🏠Private
📌37% report extra call/service prior to MatLeave
📌<8% have RVUs prorated for MatLeave
📌41% had salary⬇️ during pregnancy year
📌23%: no paid MatLeave
Recommendations to ⬇️ #ASCVD with Nutrition: 1. Primary and Secondary Prevention of ASCVD: A diet consisting predominantly of fruits, vegetables, legumes, nuts, seeds, plant protein & fatty fish is optimal for the prevention of ASCVD
🥕🥬🥦🫑🥒🍅🧅🧄🥔🐟🍉🍒🍏🍊🍇🍋🍎🌶️🍈🍐🌿🌱
2. Hyperlipidemia: Replacing saturated fat with polyunsaturated and monounsaturated fat, reducing dietary cholesterol intake, and increasing intake of fiber rich foods, can all lead to a ⬇️ in LDL-C and apoB.
The Chest Pain Guidelines are now released! ahajournals.org/doi/10.1161/CI…
Top 10: CHEST PAINS
Thanks to the entire writing group and my co-cahirs: Deb Murkerjee & Phil Levy
💥First Chest Pain Guidelines @AHAScience@ACCinTouch
Top 10 messages:
#1: Chest Pain is MORE than Pain in the chest
➡️History Matters
➡️ Assess probability of chest pain symptoms being ischemic
#2:High sensitivity troponin are useful and preferred biomarker
💥No more CK/CM, no more myoglobin
@hswapnil showed that until now for CKD, every trial of other drugs has essentially failed.
Although renal function was not a 10 (or 2o or even 3o) endpoint of EMPA trials, the benefits were seen
Work by @ChristosArgyrop (🥬Lover & #Flozinator) showed Renal & CVD benefits #SGLT2i
@hswapnil@uOttawa mentioned that mechanism of how renal protection with #SGLT2i occurs unknown. But asked the proactive question: "Does it Matter?"...and now he is a cardiologists according to @JavedButler1
#ESCCongress#HOTLINE#cvPrev#STEPStudy
Can intensive tx ⬇️ CVD risk risk HTN, older 👴🧓
🫀Optimum BP remains uncertain in older pt: differing rec's worldwide
🫀🇨🇳 age 60-80y, 9624 pts RCT, >50% Home BP cuff provided
🫀Intensive 110-130 SBP vs 130-150: 26% benefit with int tx
#ESCCongress#STEPStudy
🫀 No diff in afib, coronary revasc, Mortality but all other endpoints significant
🫀 Safe: Hypotension more common in Intensive arm but no great syncope
🫀 No subgroup diff
How low should we go? Lower! @NEJMnejm.org/doi/full/10.10… @Steph_Achenbach
#ESCCongress#STEPStudy
➡️Mean age 66 (75% below age of 70)
➡️ Most with well controlled BP at entry
Context of patient heterogenity
🫀Signif impact on CV events
🫀 Tx well tolerated & achieved! (SBP 126 Intensive)
🫀Is this SPRINT? BP achieved similar to STEP